Latest reported quarter: Q2, ended Jun 2026 · reported in CLP
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
| Line item | 2026 Q2 (CLP) |
2026 Q1 (CLP) |
2025 ANNUAL (CLP) |
2025 Q4 (CLP) |
2025 Q3 (CLP) |
|---|---|---|---|---|---|
| Total Revenue as Reported | CLP 922.03B | – | – | – | CLP 735.68B |
| Total Operating Revenue | CLP 919.35B | CLP 745.99B | CLP 2.99T | CLP 760.67B | CLP 717.03B |
| Net Interest Income | CLP 463.97B | CLP 445.03B | CLP 2.07T | CLP 771.54B | CLP 438.21B |
| -Interest Income | CLP 703.95B | CLP 672.45B | CLP 3.41T | CLP 1.35T | CLP 698.80B |
| -Interest Expense | CLP 239.98B | CLP 227.42B | CLP 1.34T | CLP 604.95B | CLP 248.90B |
| Non-Interest Income | CLP 455.39B | CLP 300.96B | CLP 922.03B | -CLP 10.87B | CLP 278.82B |
| -Total Premiums Earned | CLP 2.53B | CLP 11.52B | CLP 9.20B | -CLP 3.83B | CLP 4.45B |
| -Fees and Commissions | CLP 169.80B | CLP 155.40B | CLP 607.54B | CLP 150.96B | CLP 155.80B |
| -Foreign Exchange Trading Gains | CLP 19.44B | -CLP 33.06B | CLP 268.41B | CLP 221.52B | -CLP 51.22B |
| -Other Non-Interest Income | CLP 10.18B | CLP 33.48B | CLP 30.41B | -CLP 2.73B | CLP 9.39B |
| -Gain Loss on Sale of Assets | CLP 253.44B | CLP 133.62B | -CLP 156.64B | -CLP 539.90B | CLP 160.40B |
| Credit Losses Provision | -CLP 166.01B | -CLP 115.59B | -CLP 390.45B | -CLP 127.51B | -CLP 78.06B |
| Non-Interest Expense | CLP 288.52B | CLP 278.98B | CLP 1.09T | CLP 1.82B | CLP 275.96B |
| Selling and Admin Expenses | CLP 250.45B | CLP 237.48B | CLP 912.76B | -CLP 49.70B | CLP 245.05B |
| -General & Admin Expense | CLP 250.45B | CLP 226.24B | CLP 869.97B | -CLP 63.19B | CLP 245.05B |
| Depreciation & Amortization & Depletion | CLP 24.22B | CLP 23.85B | CLP 95.11B | CLP 24.09B | CLP 23.67B |
| -Depreciation & Amortization | CLP 24.22B | CLP 23.85B | CLP 95.11B | CLP 24.09B | CLP 23.67B |
| Other Non-Interest Expenses | CLP 13.85B | -CLP 192.00M | -CLP 12.64B | -CLP 9.60B | CLP 7.24B |
| Other Income (Expense) | CLP 3.45B | -CLP 4.65B | -CLP 12.64B | -CLP 1.80B | CLP 5.07B |
| Income from Associates & Other Participating Interests | CLP 2.60B | CLP 102.00M | CLP 11.98B | CLP 3.50B | CLP 2.67B |
| Special Income (Charges) | CLP 855.00M | -CLP 4.75B | -CLP 24.62B | -CLP 5.30B | CLP 2.40B |
| -Less:Impairment of Capital Assets | CLP 154.00M | CLP 3.00M | CLP 729.00M | CLP 451.00M | – |
| -Less:Other Special Charges | -CLP 1.01B | -CLP 3.17B | -CLP 5.60B | -CLP 2.19B | -CLP 2.79B |
| Pretax Profit | CLP 468.27B | CLP 346.78B | CLP 1.50T | CLP 330.74B | CLP 379.78B |
| Tax | CLP 77.71B | CLP 78.15B | CLP 318.39B | CLP 72.05B | CLP 86.86B |
| Net Profit | CLP 390.57B | CLP 268.63B | CLP 1.19T | CLP 258.69B | CLP 292.91B |
| Profit from Continuing Operations | CLP 390.57B | CLP 268.63B | CLP 1.19T | CLP 258.69B | CLP 292.91B |
| Net Income from Discontinuous Operations | CLP 0.00 | CLP 0.00 | – | – | CLP 0.00 |
| Minority Interests | CLP 0.00 | CLP 0.00 | CLP 0.00 | CLP 0.00 | CLP 0.00 |
| Net Income to Parent Company | CLP 390.57B | CLP 268.63B | CLP 1.19T | CLP 258.69B | CLP 292.91B |
| Net Income to Common Stockholders | CLP 390.57B | CLP 268.63B | CLP 1.19T | CLP 258.69B | CLP 292.91B |
| Basic EPS | CLP 774.00 | CLP 532.00 | CLP 2,346.00 | CLP 512.00 | CLP 580.00 |
| Diluted EPS | CLP 774.00 | CLP 532.00 | CLP 2,346.00 | CLP 512.00 | CLP 580.00 |
| Dividend Per Share | CLP 0.00 | CLP 2,044.53 | CLP 1,976.90 | CLP 0.00 | CLP 0.00 |
| Occupancy and Equipment | – | CLP 13.26B | CLP 52.34B | CLP 14.18B | – |
| Professional Expense and Contract Services Expense | – | CLP 4.59B | CLP 37.66B | CLP 22.84B | – |
| -Selling & Marketing Expense | – | CLP 11.24B | CLP 42.78B | CLP 13.49B | – |
| -Less:Write Off | – | CLP 7.92B | CLP 29.49B | CLP 7.04B | CLP 386.00M |
| -Trading Gain Loss | – | – | CLP 163.11B | – | – |
| Line item | 2026 Q2 (CLP) |
2026 Q1 (CLP) |
2025 ANNUAL (CLP) |
2025 Q4 (CLP) |
2025 Q3 (CLP) |
|---|---|---|---|---|---|
| Total Assets | CLP 55.24T | CLP 55.39T | CLP 54.10T | CLP 54.10T | CLP 55.47T |
| Cash, Cash Equivalents & Federal Funds Sold | CLP 2.41T | CLP 3.20T | CLP 3.84T | CLP 3.84T | CLP 3.17T |
| -Cash and Cash Equivalents | CLP 1.84T | CLP 2.48T | CLP 3.01T | CLP 3.01T | CLP 2.64T |
| -Money Market Investments | CLP 100.97B | CLP 195.69B | CLP 357.46B | CLP 357.46B | CLP 122.07B |
| -Restricted Cash and Investments | CLP 474.99B | CLP 524.71B | CLP 475.10B | CLP 475.10B | CLP 408.79B |
| Securities Investment | CLP 8.27T | CLP 7.28T | CLP 7.24T | CLP 7.24T | CLP 7.27T |
| -Available for Sale Securities | CLP 3.78T | CLP 3.75T | CLP 3.77T | CLP 3.77T | CLP 4.06T |
| -Short Term Investments | CLP 4.48T | CLP 3.53T | CLP 3.47T | CLP 3.47T | CLP 3.21T |
| Long Term Equity Investment | CLP 89.40B | CLP 87.65B | CLP 75.83B | CLP 75.83B | CLP 83.27B |
| Derivative Assets | CLP 1.91T | CLP 2.08T | CLP 1.94T | CLP 1.94T | CLP 1.89T |
| Net Loan | CLP 38.30T | CLP 38.43T | CLP 36.85T | CLP 36.85T | CLP 38.81T |
| -Gross Loan | CLP 39.12T | CLP 39.25T | CLP 37.56T | CLP 37.56T | CLP 39.61T |
| -Allowance for Loans and Lease Losses | CLP 821.89B | CLP 825.26B | CLP 702.46B | CLP 702.46B | CLP 802.22B |
| Receivables | CLP 3.02T | CLP 3.10T | CLP 3.10T | CLP 3.10T | CLP 3.00T |
| -Accounts Receivable | CLP 586.82B | CLP 575.71B | CLP 170.19B | CLP 170.19B | CLP 283.02B |
| -Other Receivables | CLP 2.43T | CLP 2.52T | CLP 2.93T | CLP 2.93T | CLP 2.71T |
| Net PPE | CLP 359.17B | CLP 372.65B | CLP 392.94B | CLP 392.94B | CLP 394.49B |
| -Gross PPE | CLP 944.68B | CLP 949.28B | CLP 959.61B | CLP 959.61B | CLP 954.31B |
| -Accumulated Depreciation | -CLP 585.51B | -CLP 576.64B | -CLP 566.67B | -CLP 566.67B | -CLP 559.81B |
| Goodwill and Other Intangible Assets | CLP 179.14B | CLP 176.03B | CLP 207.99B | CLP 207.99B | CLP 168.13B |
| -Other Intangible Assets | CLP 179.14B | CLP 176.03B | CLP 191.27B | CLP 191.27B | CLP 168.13B |
| Prepaid Assets | CLP 52.96B | CLP 50.88B | CLP 39.42B | CLP 39.42B | CLP 58.16B |
| Deferred Assets | CLP 588.27B | CLP 562.39B | CLP 331.83B | CLP 331.83B | CLP 562.61B |
| Assets Held for Sale | CLP 30.10B | CLP 25.81B | CLP 40.58B | CLP 40.58B | CLP 29.31B |
| Other Assets | CLP 36.69B | CLP 27.99B | CLP 31.77B | CLP 31.77B | CLP 34.72B |
| Total Liabilities | CLP 49.52T | CLP 49.93T | CLP 47.42T | CLP 47.42T | CLP 49.79T |
| Total Deposits | CLP 29.77T | CLP 30.13T | CLP 28.95T | CLP 28.95T | CLP 29.46T |
| Federal Funds Purchased and Securities Sold Under Agreement to Repurchase | CLP 140.59B | CLP 205.98B | CLP 286.92B | CLP 286.92B | CLP 168.08B |
| Derivative Product Liabilities | CLP 2.29T | CLP 2.42T | CLP 2.38T | CLP 2.38T | CLP 2.10T |
| Short-Term Debt and Capital Lease Obligation | CLP 26.45B | CLP 21.88B | CLP 23.57B | CLP 23.57B | CLP 25.60B |
| -Current Capital Lease Obligation | CLP 26.45B | CLP 21.88B | CLP 23.57B | CLP 23.57B | CLP 25.00B |
| Trading Liabilities | CLP 1.33B | CLP 1.12B | CLP 512.00M | CLP 512.00M | CLP 1.38B |
| Payables | CLP 1.11T | CLP 1.19T | CLP 902.15B | CLP 902.15B | CLP 1.30T |
| -Accounts Payable | CLP 495.84B | CLP 539.56B | CLP 429.86B | CLP 429.86B | CLP 516.10B |
| -Total Tax Payable | CLP 17.80B | CLP 62.32B | CLP 38.13B | CLP 38.13B | CLP 54.32B |
| -Dividends Payable | CLP 21.71B | CLP 20.95B | CLP 16.79B | CLP 16.79B | CLP 17.63B |
| -Other Payable | CLP 574.61B | CLP 569.38B | CLP 417.37B | CLP 417.37B | CLP 707.22B |
| Long Term Debt and Capital Lease Obligation | CLP 13.46T | CLP 13.38T | CLP 13.24T | CLP 13.24T | CLP 14.01T |
| -Long Term Debt | CLP 13.42T | CLP 13.34T | CLP 13.18T | CLP 13.18T | CLP 13.96T |
| -Long Term Capital Lease Obligation | CLP 49.13B | CLP 46.90B | CLP 50.77B | CLP 50.77B | CLP 54.70B |
| Non-Current Liabilities | CLP 1.23T | CLP 1.01T | CLP 483.78B | CLP 483.78B | CLP 1.37T |
| Non-Current Deferred Liabilities | CLP 39.28B | CLP 40.48B | CLP 39.23B | CLP 39.23B | CLP 37.63B |
| Convertible preferred securities | CLP 0.00 | CLP 0.00 | CLP 0.00 | CLP 0.00 | CLP 0.00 |
| Liabilities of Discontinued Operations | CLP 0.00 | CLP 0.00 | – | – | CLP 0.00 |
| Other Liabilities | CLP 1.43T | CLP 1.52T | CLP 973.41B | CLP 973.41B | CLP 1.32T |
| Total Equity | CLP 5.72T | CLP 5.46T | CLP 6.69T | CLP 6.69T | CLP 5.68T |
| Stockholders' Equity | CLP 5.72T | CLP 5.46T | CLP 6.69T | CLP 6.69T | CLP 5.68T |
| Capital Stock | CLP 2.42T | CLP 2.42T | CLP 2.42T | CLP 2.42T | CLP 2.42T |
| -Common Stock | CLP 2.42T | CLP 2.42T | CLP 2.42T | CLP 2.42T | CLP 2.42T |
| Retained Earnings | CLP 2.93T | CLP 2.54T | CLP 3.25T | CLP 3.25T | CLP 3.02T |
| Gains/Losses Not Affecting Retained Earnings | CLP 364.61B | CLP 500.51B | CLP 1.01T | CLP 1.01T | CLP 243.49B |
| Minority Interests | CLP 2.00M | CLP 2.00M | CLP 1.00M | CLP 1.00M | CLP 1.00M |
| -Current Debt | – | CLP 0.00 | – | – | CLP 604.00M |
| -Goodwill | – | – | CLP 16.71B | CLP 16.71B | – |
| Employee Benefits | – | – | CLP 140.15B | CLP 140.15B | – |
| Line item | 2026 Q2 (CLP) |
2026 Q1 (CLP) |
2025 ANNUAL (CLP) |
2025 Q4 (CLP) |
2025 Q3 (CLP) |
|---|---|---|---|---|---|
| Operating Cash Flow | -CLP 218.82B | -CLP 177.76B | CLP 826.08B | CLP 252.88B | -CLP 1.19T |
| Net cash flow from continuing operations | -CLP 218.82B | -CLP 177.76B | CLP 826.08B | CLP 252.88B | -CLP 1.19T |
| Net Income from Continuing Operations | CLP 390.57B | CLP 268.63B | CLP 1.19T | CLP 12.35B | CLP 539.25B |
| Gain/Loss from Continuing Operations | CLP 18.61B | CLP 242.29B | CLP 458.01B | -CLP 40.46B | CLP 167.52B |
| Depreciation & Depletion & Amortization | CLP 24.22B | CLP 23.85B | CLP 95.11B | CLP 24.09B | CLP 23.67B |
| Deferred Tax | -CLP 25.70B | CLP 3.36B | -CLP 9.72B | -CLP 3.81B | CLP 1.07B |
| Other Non-Cash Items | CLP 844.00M | CLP 11.89B | CLP 52.37B | CLP 85.57B | -CLP 52.98B |
| Change in Working Capital | -CLP 818.18B | -CLP 862.25B | -CLP 1.42T | -CLP 136.62B | -CLP 1.80T |
| -Change in Receivables | CLP 180.82B | -CLP 786.08B | CLP 263.62B | CLP 1.66T | -CLP 1.82T |
| -Change in Loans | -CLP 70.47B | -CLP 1.37T | -CLP 588.19B | -CLP 77.29B | -CLP 129.52B |
| -Change in Other Working Capital | -CLP 928.54B | CLP 1.30T | -CLP 1.09T | -CLP 1.72T | CLP 150.17B |
| Net cash flow from investing | -CLP 15.13B | -CLP 12.89B | -CLP 1.19T | -CLP 1.15T | -CLP 13.67B |
| Net Cash Flow from Continuing Investing Activities | -CLP 15.13B | -CLP 12.89B | -CLP 1.19T | -CLP 1.15T | -CLP 13.67B |
| Net PPE Purchase and Sale | -CLP 4.05B | -CLP 529.00M | -CLP 9.64B | -CLP 5.83B | -CLP 363.00M |
| Net Intangibles Purchase and Sale | -CLP 14.33B | -CLP 12.39B | -CLP 58.60B | -CLP 18.91B | -CLP 13.34B |
| Net Business Purchase and Sale | CLP 0.00 | CLP 0.00 | CLP 0.00 | CLP 0.00 | CLP 0.00 |
| Financing Cash Flow | -CLP 175.63B | -CLP 990.54B | CLP 110.76B | -CLP 52.11B | CLP 806.85B |
| Net Cash Flow from Continuing Financing Activities | -CLP 175.63B | -CLP 990.54B | CLP 110.76B | -CLP 52.11B | CLP 806.85B |
| Net Issuance Payments of Debt | -CLP 175.63B | CLP 19.38B | CLP 1.02T | -CLP 140.61B | CLP 806.85B |
| Cash Dividends Paid | CLP 0.00 | -CLP 1.01T | -CLP 995.38B | CLP 0.00 | CLP 0.00 |
| Ending Cash Balance | CLP 3.78T | CLP 4.20T | CLP 2.93T | CLP 2.93T | CLP 5.16T |
| Net Change in Cash | -CLP 409.58B | -CLP 1.18T | -CLP 252.25B | -CLP 948.63B | -CLP 400.02B |
| Beginning Cash Balance | CLP 4.20T | CLP 5.32T | CLP 3.26T | CLP 5.16T | CLP 5.52T |
| Effect of Exchange Rate Changes | -CLP 11.17B | CLP 61.09B | -CLP 78.11B | -CLP 56.97B | CLP 44.93B |
| Free Cash Flow | -CLP 240.03B | -CLP 195.75B | CLP 748.78B | CLP 227.59B | -CLP 1.21T |
| Net Investment Purchase and Sale | – | – | -CLP 1.09T | – | – |
| Net Other Investing Changes | – | – | -CLP 30.90B | – | – |
| Change in Federal Funds and Securities Sold for Repurchase | – | – | CLP 0.00 | – | – |
| Net Other Financing Activities | – | – | CLP 88.50B | – | – |
No comments yet — be the first to weigh in on BCH.